GABAB-GIRK2-mediated signaling in Down syndrome.
paper
Cited
Public
Unavailable
- Authors
- Cramer, Nathan P; Best, Tyler K; Stoffel, Marcus; Siarey, Richard J; Galdzicki, Zygmunt
- Year
- 2010
- Journal
- Advances in pharmacology (San Diego, Calif.)
- PMID
- 20655490
- DOI
- 10.1016/S1054-3589(10)58015-3
Down syndrome (DS) results from the presence of an extra copy of genes on the long-arm of chromosome 21. Aberrant expression of these trisomic genes leads to widespread neurological changes that vary in their severity. However, how the presence of extra genes affects the physiological and behavioral phenotypes associated with DS is not well understood. The most likely cause of the complex DS phenotypes is the overexpression of dosage-sensitive genes. However, other factors, such as the complex interactions between gene products as proteins and noncoding RNAs, certainly play significant roles contributing to the spectrum of severity. Here we will review evidence regarding how the overexpression of one particular gene encoding for G-protein-activated inward rectifying potassium type 2 (GIRK2) channel subunit and its coupling to GABA(B) receptors may contribute to a range of mental and functional disabilities in DS.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Synaptic and intrinsic membrane defects disrupt early neural network dynamics in Down syndrome. | Hannan SB et al. | β | 2026 | β |
| Synaptic and intrinsic membrane defects disrupt early neural network dynamics in Down syndrome | Hannan SB et al. | β | 2025 | β |
| The Role of GABA Pathway Components in Pathogenesis of Neurodevelopmental Disorders. | Marilovtseva EV et al. | β | 2025 | β |
| Activin A Reduces GIRK Current to Excite Dentate Gyrus Granule Cells. | Zheng F et al. | β | 2022 | β |
| GABA<sub>B</sub> Receptors and Cognitive Processing in Health and Disease. | Vlachou S | β | 2022 | β |
| GIRK2 Channels in Down Syndrome and Alzheimer's Disease. | Kleschevnikov A | β | 2022 | β |
| Neuronal G protein-gated K<sup>+</sup> channels. | Luo H et al. | β | 2022 | β |
| Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system. | Jeremic D et al. | β | 2021 | β |
| Down syndrome. | Rafii MS et al. | β | 2019 | β |
| GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome. | Zorrilla de San Martin J et al. | β | 2018 | β |
| Inhibitory Signaling to Ion Channels in Hippocampal Neurons Is Differentially Regulated by Alternative Macromolecular Complexes of RGS7. | Ostrovskaya OI et al. | β | 2018 | β |
| Loss of TrkB Signaling in Parvalbumin-Expressing Basket Cells Results in Network Activity Disruption and Abnormal Behavior. | Xenos D et al. | β | 2018 | β |
| A KCNJ6 gene polymorphism modulates theta oscillations during reward processing. | Kamarajan C et al. | β | 2017 | β |
| Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome. | Kleschevnikov AM et al. | β | 2017 | β |
| Loss of Ξ΄-GABA<sub>A</sub> receptor-mediated tonic currents in the adult prelimbic cortex following adolescent alcohol exposure. | Centanni SW et al. | β | 2017 | β |
| Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome. | RoncacΓ© V et al. | β | 2017 | β |
| Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome. | Caraci F et al. | β | 2017 | β |
| GABAergic hyperinnervation of dentate granule cells in the Ts65Dn mouse model of down syndrome: Exploring the role of App. | Mojabi FS et al. | β | 2016 | β |
| G Protein-Gated K<sup>+</sup> Channel Ablation in Forebrain Pyramidal Neurons Selectively Impairs Fear Learning. | Victoria NC et al. | β | 2016 | β |
| Infantile spasms in down syndrome: Rescue by knockdown of the GIRK2 channel. | Joshi K et al. | β | 2016 | β |
| Isolation of proflavine as a blocker of G protein-gated inward rectifier potassium channels by a cell growth-based screening system. | Kawada H et al. | β | 2016 | β |
| Altered intrinsic and network properties of neocortical neurons in the Ts65Dn mouse model of Down syndrome. | Cramer NP et al. | β | 2015 | β |
| Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction. | Mayfield J et al. | β | 2015 | β |
| GIRK Channels: A Potential Link Between Learning and Addiction. | Tipps ME et al. | β | 2015 | β |
| Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations. | Gardiner KJ | β | 2015 | β |
| Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage. | Souchet B et al. | β | 2014 | β |
| Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits. | Zhang L et al. | β | 2014 | β |
| Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome. | Das D et al. | β | 2014 | β |
| RGS7/GΞ²5/R7BP complex regulates synaptic plasticity and memory by modulating hippocampal GABABR-GIRK signaling. | Ostrovskaya O et al. | β | 2014 | β |
| Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome. | Wang X et al. | β | 2013 | β |
| Prospects for improving brain function in individuals with Down syndrome. | Costa AC et al. | β | 2013 | β |
| Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists. | Kleschevnikov AM et al. | β | 2012 | β |
| Discoveries in Down syndrome: moving basic science to clinical care. | Kleschevnikov AM et al. | β | 2012 | β |
| Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome. | Best TK et al. | β | 2012 | β |
| From abnormal hippocampal synaptic plasticity in down syndrome mouse models to cognitive disability in down syndrome. | Cramer N et al. | β | 2012 | β |
| GABAergic circuit dysfunctions in neurodevelopmental disorders. | Chattopadhyaya B et al. | β | 2012 | β |
| Genetic analysis of Down syndrome facilitated by mouse chromosome engineering. | Zhang L et al. | β | 2012 | β |
| Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. | Kleschevnikov AM et al. | β | 2012 | β |
| Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndrome. | Vidal V et al. | β | 2012 | β |
| Synaptic pathology of Down syndrome. | Garner CC et al. | β | 2012 | β |
| Trisomy 21 and early brain development. | Haydar TF et al. | β | 2012 | β |
| An assessment of the vestibulo-ocular reflex (VOR) in persons with Down syndrome. | Costa AC | β | 2011 | β |